Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets
- PMID: 14727881
- PMCID: PMC2750472
- DOI: 10.1208/pt020206
Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets
Abstract
The effect of the concentration of hydrophilic (hydroxypropyl methylcellulose [HPMC]) and hydrophobic (hydrogenated castor oil [HCO]) products, fillers (lactose and dibasic calcium phosphate), and buffers (sodium bicarbonate, calcium carbonate, and sodium citrate) on naproxen release rate was studied. Matrix tablets were prepared by double compression, and in vitro dissolution tests were performed. The dissolution results showed that an increased amount of HPMC or hydrogenated castor oil resulted in reduced drug release. The inclusion of buffers in the HPMC matrix tablets enhanced naproxen release. For HCO tablets, only sodium bicarbonate enhanced naproxen release. The presence of lactose on HPMC matrix tablets did not show a significantly different result from that obtained with the formulation containing dibasic calcium phosphate as a filler. However, for the tablets containing HCO, the presence of lactose significantly enhanced the naproxen release rate. The matrix-forming materials in this study were suitable for use in sustained-release tablets containing naproxen. The drug release can be modulated by adding suitable amounts of diluents and buffers.
Similar articles
-
Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.Drug Dev Ind Pharm. 2003 Jan;29(1):79-88. doi: 10.1081/ddc-120016686. Drug Dev Ind Pharm. 2003. PMID: 12602495
-
Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.AAPS PharmSciTech. 2012 Dec;13(4):1073-83. doi: 10.1208/s12249-012-9829-9. Epub 2012 Aug 21. AAPS PharmSciTech. 2012. PMID: 22907778 Free PMC article.
-
Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation.AAPS PharmSciTech. 2008;9(2):675-83. doi: 10.1208/s12249-008-9094-0. Epub 2008 May 24. AAPS PharmSciTech. 2008. PMID: 18500558 Free PMC article.
-
Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.AAPS PharmSciTech. 2003;4(3):E31. doi: 10.1208/pt040331. AAPS PharmSciTech. 2003. PMID: 14621963 Free PMC article.
-
In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium.Drug Deliv. 2007 Mar;14(3):163-9. doi: 10.1080/10717540601098682. Drug Deliv. 2007. PMID: 17454036 Clinical Trial.
Cited by
-
Gelation phase diagrams of colloidal rod systems measured over a large composition space.RSC Adv. 2022 Apr 27;12(20):12902-12912. doi: 10.1039/d2ra00609j. eCollection 2022 Apr 22. RSC Adv. 2022. PMID: 35496333 Free PMC article.
-
Effect of drying methods on swelling, erosion and drug release from chitosan-naproxen sodium complexes.AAPS PharmSciTech. 2008;9(1):1-12. doi: 10.1208/s12249-007-9001-0. Epub 2007 Dec 29. AAPS PharmSciTech. 2008. PMID: 18446455 Free PMC article.
-
Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.AAPS PharmSciTech. 2007 Jun 15;8(2):Article 44. doi: 10.1208/pt0802044. AAPS PharmSciTech. 2007. PMID: 17622119 Free PMC article.
-
Characterizing Phase Transitions of Microfibrillated Cellulose Induced by Anionic and Cationic Surfactants.Langmuir. 2023 Sep 5;39(35):12346-12356. doi: 10.1021/acs.langmuir.3c01347. Epub 2023 Aug 24. Langmuir. 2023. PMID: 37616521 Free PMC article.
-
Development of sustained release capsules containing "coated matrix granules of metoprolol tartrate".AAPS PharmSciTech. 2010 Sep;11(3):1306-14. doi: 10.1208/s12249-010-9501-1. Epub 2010 Aug 19. AAPS PharmSciTech. 2010. PMID: 20721649 Free PMC article.
References
-
- Todd PA, Clissold SP. Naproxen: a reappraisal of its pharmacology, and use in rheumatic diseases and pain states. Drugs. 1990;40:91–137. - PubMed
-
- Pather S, Russell I, Syce J, Neau S. Sustained release theophylline tablets by direct compression, Part 1: formulation andIn vitro testing. Int J Pharm. 1998;164:1–10. doi: 10.1016/S0378-5173(97)00348-7. - DOI
-
- Kibbe A. Handbook of Pharmaceutical Excipients. Washington: American Pharmaceutical Association and The Pharmaceutical Society of Great Britain; 1986. pp. 49–50.
-
- Lachman L, Lieberman HA, Kanig JL. Pharmaceutical Dosage Forms-Tablets. 2nd ed. New York: marcel Dekker Inc; 1989. pp. 13–13.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources